TRYP THRAPEUTICS INC by Tryp Therapeutics Inc.
(OTCQB:TRYPF)
$0.0562
0[0.00%]
At close: May 1
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
TRYPF

FAQ

Q

How do I buy TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (TRYPF) stock?

A

You can purchase shares of TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (OTCQB: TRYPF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TRYP THRAPEUTICS INC by Tryp Therapeutics Inc.'s (TRYPF) competitors?

A

There are no as such competitors for TRYP THRAPEUTICS INC by Tryp Therapeutics Inc..

Q

What is the target price for TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (TRYPF) stock?

A

The latest price target for TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (OTCQB: TRYPF) was reported by Ladenburg Thalmann on Thursday, January 5, 2023. The analyst firm set a price target for 1.50 expecting TRYPF to rise to within 12 months (a possible 2569.04% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (TRYPF)?

A

The stock price for TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (OTCQB: TRYPF) is $0.0562 last updated May 1, 2024 at 3:17 PM EDT.

Q

Does TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (TRYPF) pay a dividend?

A

There are no upcoming dividends for TRYP THRAPEUTICS INC by Tryp Therapeutics Inc..

Q

When is TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (OTCQB:TRYPF) reporting earnings?

A

TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. does not have any upcoming earnings scheduled.

Q

Is TRYP THRAPEUTICS INC by Tryp Therapeutics Inc. (TRYPF) going to split?

A

There is no upcoming split for TRYP THRAPEUTICS INC by Tryp Therapeutics Inc..